313 related articles for article (PubMed ID: 12433692)
1. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
Tsang JY; Chai JG; Lechler R
Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
3. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
4. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
5. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
6. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
[TBL] [Abstract][Full Text] [Related]
7. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
9. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
10. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
[TBL] [Abstract][Full Text] [Related]
11. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
[TBL] [Abstract][Full Text] [Related]
12. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
Maroto R; Shen X; König R
J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
[TBL] [Abstract][Full Text] [Related]
13. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.
Tobian AA; Canaday DH; Harding CV
J Immunol; 2004 Oct; 173(8):5130-7. PubMed ID: 15470057
[TBL] [Abstract][Full Text] [Related]
14. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
[TBL] [Abstract][Full Text] [Related]
15. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
17. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype.
Buatois V; Baillet M; Bécart S; Mooney N; Leserman L; Machy P
J Immunol; 2003 Dec; 171(11):5812-9. PubMed ID: 14634090
[TBL] [Abstract][Full Text] [Related]
18. Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils.
Miyake K; Shiozawa N; Nagao T; Yoshikawa S; Yamanishi Y; Karasuyama H
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1111-1116. PubMed ID: 28096423
[TBL] [Abstract][Full Text] [Related]
19. Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation.
Aubin É; Proulx DP; Trépanier P; Lemieux R; Bazin R
Clin Immunol; 2011 Dec; 141(3):273-83. PubMed ID: 21824820
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
